PROQR THERAPEUTICS EO-04 Financial Flexibility Index
PROQR THERAPEUTICS EO-04 financial flexibility index. PROQR THERAPEUTICS EO-04 (0PQ) has a Financial Flexibility Index of -0.20x as of December 2025. Free cash flow of €-12.83 Million (operating CF €-13.36 Million minus capex €526.00K) represents 0% of total liabilities (€63.38 Million). See 0PQ cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of PROQR THERAPEUTICS EO-04 (2021–2025)
Financial flexibility index of PROQR THERAPEUTICS EO-04 from 2021 to 2025. Historical Financial Flexibility Index trend for PROQR THERAPEUTICS EO-04 across 5 annual periods. Explore 0PQ cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
PROQR THERAPEUTICS EO-04 Financial Flexibility Index by Year (2021–2025)
PROQR THERAPEUTICS EO-04 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for PROQR THERAPEUTICS EO-04. For the full cash flow conversion analysis, see 0PQ cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.82x | €-51.77 Million | €-52.79 Million | €63.38 Million | ▼ -85.4% |
| 2024 | -0.44x | €-34.98 Million | €-36.39 Million | €79.40 Million | ▼ -285.5% |
| 2023 | 0.24x | €22.92 Million | €21.55 Million | €96.49 Million | ▲ +136.7% |
| 2022 | -0.65x | €-67.80 Million | €-68.51 Million | €104.64 Million | ▼ -144.5% |
| 2021 | -0.26x | €-25.53 Million | €-26.01 Million | €96.35 Million | — |